CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- 4 Open-market sale Chief Scientific Officer sold 2,725 shares at $3.94 ($10,737)
- 4 Exercise or conversion Chief Scientific Officer acquired 75,998 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Scientific Officer acquired 25,012 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Conversion Chief Financial Officer acquired 2,830 shares (conversion)
- 4 Conversion Chief Executive Officer acquired 84,973 shares (conversion)
- 4 Conversion Director acquired 63,005 shares (conversion)
- 4 Conversion Director acquired 927,562 shares (conversion)
- 4 Conversion 10% owner acquired 3,795,150 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 15 of 16 · 313 filings